Page last updated: 2024-11-02

pifithrin and Pulmonary Hypertension

pifithrin has been researched along with Pulmonary Hypertension in 1 studies

pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source

Research Excerpts

ExcerptRelevanceReference
" We therefore explored the involvement of p53 in the monocrotaline (MCT) rat model of pulmonary hypertension (PH) and the pathophysiological consequences of p53 inactivation in response to animal treatment with pifithrin-α (PFT, an inhibitor of p53 activity)."3.81Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats. ( Eddahibi, S; Fadel, E; Humbert, M; Jacquin, S; Londoño-Vallejo, A; Mercier, O; Mignotte, B; Richard, S; Rincheval, V, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacquin, S1
Rincheval, V1
Mignotte, B1
Richard, S1
Humbert, M1
Mercier, O1
Londoño-Vallejo, A1
Fadel, E1
Eddahibi, S1

Other Studies

1 other study available for pifithrin and Pulmonary Hypertension

ArticleYear
Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats.
    PloS one, 2015, Volume: 10, Issue:6

    Topics: Animals; Apoptosis; Benzothiazoles; Cell Proliferation; Humans; Hypertension, Pulmonary; Hypertrophy

2015